News
7d
Zacks Investment Research on MSNEli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...
13h
Zacks Investment Research on MSNHow Will Eli Lilly's Oncology Drugs Perform in Q2 Earnings?Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is ...
President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...
Eli Lilly (LLY) shares rallied 14.3% in the last trading session to close at $839.96. ... Merck's consensus EPS estimate for the upcoming report has changed -4% over the past month to $2.16.
Lilly’s new approach to cholesterol. Eli Lilly’s experimental cholesterol drug doubled patients’ HDL (Opens in a new window), or good cholesterol, setting the stage for a race between the ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
The Series B financing was led by funds managed by BlackRock and supported by new healthcare and technology investors, including Eli Lilly and Company, Merck Global Health Innovation Fund (Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results